Monday, 23 September 2019

Biologics News

  • Studies on MabThera delivery method positive

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 10 Dec, 2012

    Singapore: Two studies by Roche has demonstrated that a fixed dose of MabThera (rituximab) can be administered subcutaneously, potentially allowing patients to spend less time at infusion c...Read more

  • Merck to develop processes for stem cell cultures

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 20 Sep, 2012

    Singapore: Merck Millipore, the life science division of Merck, and the Institute of Bioprocess Engineering and Pharmaceutical Technology, Mittelhessen University of Applied Sciences have c...Read more

  • Scientists find cellular origin of cervical cancer

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 14 Jun, 2012

    Singapore: A team of scientists from A*STAR's Institute of Medical Biology (IMB) and Genome Institute of Singapore (GIS), together with clinicians from Boston's Brigham and Women's Hospital...Read more

  • Analytical instruments market to soar in China

    Biologics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 26 Nov, 2012

    Singapore: China is soon expected to become a sales hub for lab analytical instruments as international companies speed up localized manufacturing in tandem with the country's economic grow...Read more

  • China Biologic to report Q2 results

    Biologics |  Company results | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2013

    Singapore: China Biologic Products, a leading fully integrated plasma-based biopharmaceutical company in China, will release its second quarter 2013 financial results on Tuesday, August 6, ...Read more

  • Oncotest, Debiopharm identify biomarker candidates

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 25 Apr, 2013

    Singapore: Germany-based Oncotest and Debiopharm, a Swiss-based global biopharmaceutical group, have completed first biomarker projects at Oncotest. The pharmacological data was generated ...Read more

  • EMA recommends MSD's melanoma drug

    Biologics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 27 May, 2015

    Singapore: European Medicines Agency (EMA) has recommended granting a marketing authorization for Merck Sharp And Dohme's Keytruda (pembrolizumab) as monotherapy for the treatment of adult ...Read more

  • Intrexon appoints new VP and CIO

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 20 Nov, 2013

    Singapore: US-based Intrexon, a synthetic biology company, has appointed Dr Peter Seufer-Wasserthal as VP, business development for Europe and Asia and Ms Dana Di Ferdinando as chief inform...Read more

  • China Biologic clocks sales of $53.6 mn

    Biologics |  Company results | By BioSpectrum Bureau  | 0 Comment | 07 Aug, 2013

    Singapore: China Biologic Products reported its unaudited financial results for the second quarter of 2013. Total sales in the second quarter of 2013 increased by 6.2 percent to $53.6 milli...Read more

  • China Biologic reports 21.1% growth in sales revenue

    Biologics |  Company results | By BioSpectrum Bureau  | 0 Comment | 10 Aug, 2012

    Singapore: China Biologic Products, a leading fully integrated plasma-based biopharmaceutical company in China, announced its unaudited financial results for the second quarter of 2012. Tot...Read more

  • GE launches new software for molecular screening

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2013

    Singapore: GE Healthcare has launched Biacore T200 Software v.2.0, offering researchers a flexible and powerful tool for efficient processing of molecular interaction data. It facilitates ...Read more

  • Biochips firm AyoxxA gets $3.37 million funding

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 21 Sep, 2012

    Singapore: AyoxxA Biosystems, an international biotechnology company, has closed a $3.37 million (2.6 million Euro) series A financing round. The round was led by Wellington Partners Ventur...Read more

  • China's JHL Biotech raises $35 million

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jun, 2014

    Singapore: China based emerging biopharmaceutical company, JHL Biotech, has closed a Series B financing round of $35 million, funded by Milestone Capital and a consortium of Taiwan venture ...Read more

  • bioCSL inks a deal with Immucor

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 21 Jul, 2014

    Singapore: BioCSL has inked a deal with US-based Immucor to distribute transfusion testing technology in Australia and New Zealand. BioCSL has already started distribution of Immucor's capt...Read more

  • Promega opens new facility in Shanghai

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 19 Nov, 2012

    Singapore: Promega opened a new facility in Shanghai for its China operations. The new site for Shanghai Promega Biological Products replaces an existing molecular biology reagent productio...Read more

  • Novel protein complex to combat gastric cancer

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jul, 2014

    Singapore: A team of scientists from Cancer Science Institute of Singapore (CSI) at National University of Singapore (NUS) have discovered  a protein named IL23A as part of human stomach's...Read more

  • China Biologic names David Gao as CEO

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 14 May, 2012

    Singapore: China Biologic Products, one of the leading plasma-based biopharmaceutical companies in China, has appointed Chairman David (Xiaoying) Gao to the additional position of chief exe...Read more

  • Shimadzu launches smart device enabled HPLC system

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2014

    Singapore: Japan-based global analytics technology provider, Shimadzu, has launched i-Series of new industry standard HPLCs (High Performance Liquid Chromatograph) systems, with built-in to...Read more



Podcast

 

Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls